Dr. Kevin Glenn is a Monsanto Senior Science Fellow and the Scientific Affairs Pipeline Lead within Monsanto Regulatory. He is author of more than 62 scientific publications and 22 patents, a co-inventor of two cholesterol improving therapeutics, and also the co-inventor of a wound-healing agent.
Dr. Glenn obtained his B.S. degree in microbiology from the California State Polytechnic University, Pomona, and his Ph.D. in cell biology from the University of California, Irvine. He joined Monsanto in 1983 after completing an American Heart Association postdoctoral research fellowship at the University of Washington, Seattle. At Monsanto, he has held several roles, including Acting Director of Cardiovascular Research for G.D. Searle.
Dr. Glenn is past Chair of the International Food Biotechnology Committee of the International Life Sciences Institute (ILSI). Previously he chaired the ILSI Task Force on Nutritional and Safety Assessments of GM Crops and the Subcommittee on DNA/Protein Detection within the industry-wide Agricultural Biotechnology Stewardship Technical Committee (ABSTC).